PD-L1 Biomarker Testing Market By Product Type (PD-L1 22C3 Assay Kit, PD-L1 SP142 Assay Kit, PD-L1 28-8 Assay Kit, and PD-L1 263 Assay Kit), By Application (Non-Small Cell Lung Cancer (NSCLC), Renal Cell Carcinoma, Ovarian Cancer, Melanoma, Haematological Malignancies, Gastrointestinal Tract Malignancy, and Other), By End-user (Hospitals, Cancer Research Institutes, Diagnostic Laboratories, and Others), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034
Report Overview The PD-L1 Biomarker Testing Market Size is expected to be worth around US$ 1.6 billion by 2034 from US$ 0.7 billion in 2024, growing at a CAGR of 8.3% during the fore...
